In Situ Gelling Dexamethasone Oromucosal Formulation: Physical Characteristics Influencing Drug Delivery
The study focuses on the development of an in situ gelling dexamethasone (DEX) oromucosal formulation designed for the treatment of aphthous stomatitis. Three series of formulations were prepared; a first series containing DEX suspended, a second series containing DEX and, in addition, mint essentia...
Saved in:
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-01-01
|
Series: | Gels |
Subjects: | |
Online Access: | https://www.mdpi.com/2310-2861/11/1/26 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832588436672872448 |
---|---|
author | Daniel Krchňák Ľudmila Balážová Michal Hanko Dominika Žigrayová Miroslava Špaglová |
author_facet | Daniel Krchňák Ľudmila Balážová Michal Hanko Dominika Žigrayová Miroslava Špaglová |
author_sort | Daniel Krchňák |
collection | DOAJ |
description | The study focuses on the development of an in situ gelling dexamethasone (DEX) oromucosal formulation designed for the treatment of aphthous stomatitis. Three series of formulations were prepared; a first series containing DEX suspended, a second series containing DEX and, in addition, mint essential oil (EO), and a third series containing EO and DEX solubilized in propylene glycol (PG). In the composition, polymers in the role of mucoadhesive agent were interchanged (hydroxypropyl methylcellulose (HPMC), hydroxypropyl cellulose (HPC), hydroxyethyl cellulose (HEC), methyl cellulose (MC), carboxymethyl cellulose (CMC), and sodium carboxymethyl cellulose (NaCMC). Specifically, DEX was incorporated at a concentration of 0.1% (<i>w</i>/<i>w</i>) in each formulation. The influence of mint EO and DEX solubilization on the physical properties (pH measurements, rheological analysis, swelling ability, and texture analysis) and in vitro drug release was studied. Key findings revealed that HPMC-based formulation containing mint EO and PG exhibited best swelling properties (700 ± 46% after 5 h), adequate adhesiveness and in vitro drug release (34.7 ± 5.9%). Furthermore, the irritation potential assessed via the hen’s egg test on the chorioallantoic membrane (HET-CAM) demonstrated low irritancy risk. Finally, Fourier-transform infrared spectroscopy (FT-IR) showed no incompatibility between DEX and excipients. Overall, the research highlights the potential of mucoadhesive systems in improving the therapeutic efficacy of oromucosal drug delivery for managing painful oral lesions. |
format | Article |
id | doaj-art-b688881ffcda4793a369cb6835ab55a4 |
institution | Kabale University |
issn | 2310-2861 |
language | English |
publishDate | 2025-01-01 |
publisher | MDPI AG |
record_format | Article |
series | Gels |
spelling | doaj-art-b688881ffcda4793a369cb6835ab55a42025-01-24T13:33:49ZengMDPI AGGels2310-28612025-01-011112610.3390/gels11010026In Situ Gelling Dexamethasone Oromucosal Formulation: Physical Characteristics Influencing Drug DeliveryDaniel Krchňák0Ľudmila Balážová1Michal Hanko2Dominika Žigrayová3Miroslava Špaglová4Department of Galenic Pharmacy, Faculty of Pharmacy, Comenius University Bratislava, Odbojárov 10, SK-832 32 Bratislava, SlovakiaDepartment of Pharmaceutical Technology, Pharmacognosy and Botany, University of Veterinary Medicine and Pharmacy in Košice, Komenského 73, SK-041 81 Kosice, SlovakiaDepartment of Pharmaceutical Analysis and Nuclear Pharmacy, Faculty of Pharmacy, Comenius University Bratislava, Odbojárov 10, SK-832 32 Bratislava, SlovakiaDepartment of Galenic Pharmacy, Faculty of Pharmacy, Comenius University Bratislava, Odbojárov 10, SK-832 32 Bratislava, SlovakiaDepartment of Galenic Pharmacy, Faculty of Pharmacy, Comenius University Bratislava, Odbojárov 10, SK-832 32 Bratislava, SlovakiaThe study focuses on the development of an in situ gelling dexamethasone (DEX) oromucosal formulation designed for the treatment of aphthous stomatitis. Three series of formulations were prepared; a first series containing DEX suspended, a second series containing DEX and, in addition, mint essential oil (EO), and a third series containing EO and DEX solubilized in propylene glycol (PG). In the composition, polymers in the role of mucoadhesive agent were interchanged (hydroxypropyl methylcellulose (HPMC), hydroxypropyl cellulose (HPC), hydroxyethyl cellulose (HEC), methyl cellulose (MC), carboxymethyl cellulose (CMC), and sodium carboxymethyl cellulose (NaCMC). Specifically, DEX was incorporated at a concentration of 0.1% (<i>w</i>/<i>w</i>) in each formulation. The influence of mint EO and DEX solubilization on the physical properties (pH measurements, rheological analysis, swelling ability, and texture analysis) and in vitro drug release was studied. Key findings revealed that HPMC-based formulation containing mint EO and PG exhibited best swelling properties (700 ± 46% after 5 h), adequate adhesiveness and in vitro drug release (34.7 ± 5.9%). Furthermore, the irritation potential assessed via the hen’s egg test on the chorioallantoic membrane (HET-CAM) demonstrated low irritancy risk. Finally, Fourier-transform infrared spectroscopy (FT-IR) showed no incompatibility between DEX and excipients. Overall, the research highlights the potential of mucoadhesive systems in improving the therapeutic efficacy of oromucosal drug delivery for managing painful oral lesions.https://www.mdpi.com/2310-2861/11/1/26dexamethasoneaphthous stomatitismucoadhesionmint essential oilcellulose derivatives |
spellingShingle | Daniel Krchňák Ľudmila Balážová Michal Hanko Dominika Žigrayová Miroslava Špaglová In Situ Gelling Dexamethasone Oromucosal Formulation: Physical Characteristics Influencing Drug Delivery Gels dexamethasone aphthous stomatitis mucoadhesion mint essential oil cellulose derivatives |
title | In Situ Gelling Dexamethasone Oromucosal Formulation: Physical Characteristics Influencing Drug Delivery |
title_full | In Situ Gelling Dexamethasone Oromucosal Formulation: Physical Characteristics Influencing Drug Delivery |
title_fullStr | In Situ Gelling Dexamethasone Oromucosal Formulation: Physical Characteristics Influencing Drug Delivery |
title_full_unstemmed | In Situ Gelling Dexamethasone Oromucosal Formulation: Physical Characteristics Influencing Drug Delivery |
title_short | In Situ Gelling Dexamethasone Oromucosal Formulation: Physical Characteristics Influencing Drug Delivery |
title_sort | in situ gelling dexamethasone oromucosal formulation physical characteristics influencing drug delivery |
topic | dexamethasone aphthous stomatitis mucoadhesion mint essential oil cellulose derivatives |
url | https://www.mdpi.com/2310-2861/11/1/26 |
work_keys_str_mv | AT danielkrchnak insitugellingdexamethasoneoromucosalformulationphysicalcharacteristicsinfluencingdrugdelivery AT ludmilabalazova insitugellingdexamethasoneoromucosalformulationphysicalcharacteristicsinfluencingdrugdelivery AT michalhanko insitugellingdexamethasoneoromucosalformulationphysicalcharacteristicsinfluencingdrugdelivery AT dominikazigrayova insitugellingdexamethasoneoromucosalformulationphysicalcharacteristicsinfluencingdrugdelivery AT miroslavaspaglova insitugellingdexamethasoneoromucosalformulationphysicalcharacteristicsinfluencingdrugdelivery |